홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Trifluoroacetic acid → 3-[5-[3-(Aminomethyl)phenyl]-1,3,4-oxadiazol-2-yl]-5-(4-isopropylsulfonylphenyl)pyrazin-2-amine

HRID 78636
인쇄

반응식

HRID 78636 반응식
C(=O)([O-])[O-].[Na+].[Na+].[NH2:7][C:8]1[C:9]([C:15]2[O:19][C:18]([C:20]3[CH:21]=[C:22]([CH2:26][NH:27]C(=O)OC(C)(C)C)[CH:23]=[CH:24][CH:25]=3)=[N:17][N:16]=2)=[N:10][C:11](Br)=[CH:12][N:13]=1.[CH:35]([S:38]([C:41]1[CH:46]=[CH:45][C:44](B(O)O)=[CH:43][CH:42]=1)(=[O:40])=[O:39])([CH3:37])[CH3:36].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.C(O)(C(F)(F)F)=O>O1CCOCC1.[Pd]>[NH2:27][CH2:26][C:22]1[CH:21]=[C:20]([C:18]2[O:19][C:15]([C:9]3[C:8]([NH2:7])=[N:13][CH:12]=[C:11]([C:44]4[CH:43]=[CH:42][C:41]([S:38]([CH:35]([CH3:37])[CH3:36])(=[O:40])=[O:39])=[CH:46][CH:45]=4)[N:10]=3)=[N:16][N:17]=2)[CH:25]=[CH:24][CH:23]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 6422Trifluoroacetic acidHCID 10340Sodium CarbonateHCID 11776TriphenylphosphineHCID 441193274-(Isopropylsulphonyl)benzeneboronic acidHCID 59471784Tert-butyl 3-(5-(3-amino-6-bromopyrazin-2-yl)-1,3,4-oxadiazol-2-yl)benzylcarbamate

생성물 1

HCID 59471633
3-[5-[3-(Aminomethyl)phenyl]-1,3,4-oxadiazol-2-yl]-5-(4-isopropylsulfonylphenyl)pyrazin-2-amine
수율 35.8%

시약·촉매·용매 2

HCID 23938Palladium촉매HCID 312751,4-Dioxane용매

실험 절차

Sodium carbonate (335.4 μL of 2 M, 0.6708 mmol) was added to a solution of tert-butyl N-[[3-[5-(3-amino-6-bromo-pyrazin-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]methyl]carbamate (100 mg, 0.2236 mmol), (4-isopropylsulfonylphenyl)boronic acid (66.30 mg, 0.2907 mmol), palladium; triphenylphosphane (25.84 mg, 0.02236 mmol) in dioxane (5 mL) and the resulting mixture heated at 110° C. under microwave conditions for 90 min. The mixture was placed directly onto silica gel pad and washed through with diethyl ether and followed by 50% EtOAc/ petroleum ether. Product fractions were combined and concentrated in vacuo. The residue was dissolved in CH2Cl2 (10 mL) and TFA (764.9 mg, 516.8 μL, 6.708 mmol) was added. The reaction mixture was stirred at room temperature for 1 h and then concentrated in vacuo to leave an oil. This was purified by reverse phase preparative HPLC [Waters Sunfire C18, 10 μM, 100 Å column, gradient 10%-95% B (solvent A: 0.05% TFA in water; solvent B: CH3CN) over 16 minutes at 25 mL/min]. Product fractions were combined and lypholised to give the product as a yellow solid (36.05 mg, 35% yield); 1H NMR (400 MHz, DMSO) d 1.3 (d, 6H), 3.45-3.55 (m, 1H), 4.24-4.3 (m, 2H), 7.7-7.8 (m, 2H), 7.95 (d, 2H), 8.25 (d, 1H), 8.3-8.4 (br s, 2H), 8.4 (s, 1H), 8.45 (d, 2H) and 9.1 (s, 1H) ppm; MS (ES+) 451.2

후처리

  1. washwashed through with diethyl ether
  2. concentrationconcentrated in vacuo
  3. dissolutionThe residue was dissolved in CH2Cl2 (10 mL)
  4. concentrationconcentrated in vacuo
  5. customto leave an oil
  6. customThis was purified by reverse phase preparative HPLC [Waters Sunfire C18, 10 μM, 100 Å column, gradient 10%-95% B (solvent A: 0.05% TFA in water; solvent B: CH3CN) over 16 minutes at 25 mL/min]

출처 및 근거

ORD 기록
ord-97954f6682fc4420bb583cc319007d0d
출처 데이터셋
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08841308B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트